Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the best curative treatment modality for many malignant hematologic disorders. In the absence of a matched related donor, matched unrelated donors (MUDs) and haploidentical donors are the most important stem cell sources. In this regi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
December 10 2024
|
| In: |
Blood advances
Year: 2024, Jahrgang: 8, Heft: 23, Pages: 6104-6113 |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2024013719 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2024013719
|
| Verfasserangaben: | Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig, Thomas Schröder, Gesine Bug, Georg-Nikolaus Franke, Matthias Stelljes, Peter Dreger, Robert Zeiser, Daniel Teschner, Wolfgang Bethge, Matthias Eder, Matthias Edinger, Elisa Maria Amann, Christine Neuchel, Amelie Schmid-Möglich, Sandra Schmeller, Jan Beyersmann, Hubert Schrezenmeier, Joannis Mytilineos, Nicolaus Kröger, and Daniel Fürst, on behalf of the German Registry for Stem Cell Transplantation |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1927856736 | ||
| 003 | DE-627 | ||
| 005 | 20250913141612.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250610s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2024013719 |2 doi | |
| 035 | |a (DE-627)1927856736 | ||
| 035 | |a (DE-599)KXP1927856736 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Arslan, Aysenur |e VerfasserIn |0 (DE-588)1075655811 |0 (DE-627)833614967 |0 (DE-576)444443592 |4 aut | |
| 245 | 1 | 0 | |a Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany |c Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig, Thomas Schröder, Gesine Bug, Georg-Nikolaus Franke, Matthias Stelljes, Peter Dreger, Robert Zeiser, Daniel Teschner, Wolfgang Bethge, Matthias Eder, Matthias Edinger, Elisa Maria Amann, Christine Neuchel, Amelie Schmid-Möglich, Sandra Schmeller, Jan Beyersmann, Hubert Schrezenmeier, Joannis Mytilineos, Nicolaus Kröger, and Daniel Fürst, on behalf of the German Registry for Stem Cell Transplantation |
| 246 | 3 | 3 | |a Outcomes of haploidentical transplants with PT-CY vs ten/ten MUD transplants with ATG in Germany |
| 264 | 1 | |c December 10 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 3. Dezember 2024 | ||
| 500 | |a Gesehen am 10.06.2025 | ||
| 520 | |a Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the best curative treatment modality for many malignant hematologic disorders. In the absence of a matched related donor, matched unrelated donors (MUDs) and haploidentical donors are the most important stem cell sources. In this registry-based retrospective study, we compared the outcomes of allo-HSCTs from 10/10 MUDs with antithymocyte globulin (ATG)-based regimens (n = 7050) vs haploidentical transplants (Haplo-Tx) using posttransplant cyclophosphamide (PT-CY Haplo; n = 487) in adult patients with hematologic malignancies between 2010 and 2020. Cox proportional hazard-and competing risks regression models were formed to compare the outcomes. Overall survival (OS), Disease-free survival (DFS), and graft-versus-host disease (GVHD)-free and relapse-free survival (GRFS) were superior for 10/10 MUDs (OS [hazard ratio (HR), 1.27; 95% confidence interval (CI), 1.10-1.47; P = .001]; DFS [HR, 1.17; CI, 1.02-1.34; P = .022]; GRFS [HR, 1.34; CI, 1.19-1.50; P < .001]). The risk of acute GVHD (aGVHD) grade 2 to 4, aGVHD grade 3 to 4, and chronic GVHD (cGVHD) was higher in the PT-CY Haplo group than the 10/10 MUD group (aGVHD grade 2-4 [HR, 1.46; CI, 1.25-1.71; P < .001]; aGVHD grade 3-4 [HR, 1.74; CI, 1.37- 2.20; P < .001]; cGVHD [HR, 1.30; CI, 1.11-1.51; P = .001]). A lower incidence of relapse was observed in the PT-CY Haplo group (relapse: HR, 0.83; CI, 0.69-0.99; P = .038). Unrelated 10/10 matched transplantation with ATG leads to lower GVHD rates and improved survival rates compared with PT-CY Haplo transplantation in Germany. | ||
| 700 | 1 | |a Labuhn, Svenja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sala, Elisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ringhoffer, Mark |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schetelig, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schröder, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bug, Gesine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Franke, Georg-Nikolaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stelljes, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Zeiser, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teschner, Daniel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bethge, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eder, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Edinger, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Amann, Elisa Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Neuchel, Christine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmid-Möglich, Amelie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmeller, Sandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beyersmann, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schrezenmeier, Hubert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mytilineos, Joannis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kröger, Nicolaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fürst, Daniel |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d Washington, DC : American Society of Hematology, 2016 |g 8(2024), 23 vom: Dez., Seite 6104-6113 |h Online-Ressource |w (DE-627)873588312 |w (DE-600)2876449-3 |w (DE-576)48043249X |x 2473-9537 |7 nnas |a Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:23 |g month:12 |g pages:6104-6113 |g extent:10 |a Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany |
| 856 | 4 | 0 | |u https://doi.org/10.1182/bloodadvances.2024013719 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250610 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 999 | |a KXP-PPN1927856736 |e 4732829384 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"December 10 2024"}],"note":["Online veröffentlicht: 3. Dezember 2024","Gesehen am 10.06.2025"],"relHost":[{"note":["Gesehen am 27.04.21"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyBlood advances","language":["eng"],"origin":[{"publisherPlace":"Washington, DC","dateIssuedDisp":"[2016]-","publisher":"American Society of Hematology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"6104-6113","year":"2024","issue":"23","text":"8(2024), 23 vom: Dez., Seite 6104-6113","extent":"10","volume":"8"},"title":[{"title_sort":"Blood advances","title":"Blood advances"}],"id":{"zdb":["2876449-3"],"eki":["873588312"],"issn":["2473-9537"]},"recId":"873588312","pubHistory":["Vol. 1, iss. 1 (November 2016)-"],"name":{"displayForm":["American Society of Hematology"]}}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"language":["eng"],"recId":"1927856736","id":{"doi":["10.1182/bloodadvances.2024013719"],"eki":["1927856736"]},"name":{"displayForm":["Aysenur Arslan, Svenja Labuhn, Elisa Sala, Mark Ringhoffer, Johannes Schetelig, Thomas Schröder, Gesine Bug, Georg-Nikolaus Franke, Matthias Stelljes, Peter Dreger, Robert Zeiser, Daniel Teschner, Wolfgang Bethge, Matthias Eder, Matthias Edinger, Elisa Maria Amann, Christine Neuchel, Amelie Schmid-Möglich, Sandra Schmeller, Jan Beyersmann, Hubert Schrezenmeier, Joannis Mytilineos, Nicolaus Kröger, and Daniel Fürst, on behalf of the German Registry for Stem Cell Transplantation"]},"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Aysenur","display":"Arslan, Aysenur","family":"Arslan"},{"roleDisplay":"VerfasserIn","given":"Svenja","display":"Labuhn, Svenja","family":"Labuhn","role":"aut"},{"family":"Sala","roleDisplay":"VerfasserIn","display":"Sala, Elisa","given":"Elisa","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Mark","display":"Ringhoffer, Mark","family":"Ringhoffer","role":"aut"},{"role":"aut","family":"Schetelig","roleDisplay":"VerfasserIn","display":"Schetelig, Johannes","given":"Johannes"},{"family":"Schröder","given":"Thomas","roleDisplay":"VerfasserIn","display":"Schröder, Thomas","role":"aut"},{"role":"aut","family":"Bug","roleDisplay":"VerfasserIn","display":"Bug, Gesine","given":"Gesine"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Franke, Georg-Nikolaus","given":"Georg-Nikolaus","family":"Franke"},{"family":"Stelljes","roleDisplay":"VerfasserIn","display":"Stelljes, Matthias","given":"Matthias","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Dreger, Peter","given":"Peter","family":"Dreger"},{"family":"Zeiser","roleDisplay":"VerfasserIn","display":"Zeiser, Robert","given":"Robert","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Daniel","display":"Teschner, Daniel","family":"Teschner"},{"role":"aut","family":"Bethge","roleDisplay":"VerfasserIn","given":"Wolfgang","display":"Bethge, Wolfgang"},{"family":"Eder","display":"Eder, Matthias","roleDisplay":"VerfasserIn","given":"Matthias","role":"aut"},{"family":"Edinger","roleDisplay":"VerfasserIn","given":"Matthias","display":"Edinger, Matthias","role":"aut"},{"role":"aut","family":"Amann","roleDisplay":"VerfasserIn","display":"Amann, Elisa Maria","given":"Elisa Maria"},{"display":"Neuchel, Christine","roleDisplay":"VerfasserIn","given":"Christine","family":"Neuchel","role":"aut"},{"role":"aut","family":"Schmid-Möglich","roleDisplay":"VerfasserIn","given":"Amelie","display":"Schmid-Möglich, Amelie"},{"role":"aut","family":"Schmeller","display":"Schmeller, Sandra","roleDisplay":"VerfasserIn","given":"Sandra"},{"display":"Beyersmann, Jan","roleDisplay":"VerfasserIn","given":"Jan","family":"Beyersmann","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Hubert","display":"Schrezenmeier, Hubert","family":"Schrezenmeier"},{"roleDisplay":"VerfasserIn","given":"Joannis","display":"Mytilineos, Joannis","family":"Mytilineos","role":"aut"},{"family":"Kröger","roleDisplay":"VerfasserIn","given":"Nicolaus","display":"Kröger, Nicolaus","role":"aut"},{"role":"aut","given":"Daniel","roleDisplay":"VerfasserIn","display":"Fürst, Daniel","family":"Fürst"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany","title_sort":"Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany"}],"titleAlt":[{"title":"Outcomes of haploidentical transplants with PT-CY vs ten/ten MUD transplants with ATG in Germany"}]} | ||
| SRT | |a ARSLANAYSEOUTCOMESOF1020 | ||